✦ LIBER ✦

P03-94 - Collaborative study of compliance in psychotic patients with risperidone long-acting injection (RLAI) in the last 5 years

✍ Scribed by Molina Ramos, R.; Arnillas, H.; Playà, J.; Sánchez de Muniain, M.; LLiteras, M.; Hernandez, B.

Book ID: 123120083
Publisher: Elsevier Science
Year: 2011
Tongue: French
Weight: 12 KB
Volume: 26
Category: Article
ISSN: 0924-9338
DOI: 10.1016/S0924-9338(11)72968-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P03-288 - Improvement of positive and ne

P03-288 - Improvement of positive and negative symptoms in patients with schizophrenia, under risperidone long acting injection (RLAI) treatment

✍ Moruzzi, E. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 French ⚖ 11 KB

Remission in schizophrenia: one-year Ita

Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder

✍ Alessandro Rossi; Anna Bagalà; Vincenzo Del Curatolo; Francesco Scapati; Micaela 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 1 views

## Abstract ## Objectives To evaluate the maintenance of efficacy of risperidone long‐acting injectable (RLAI) in stable patients with schizophrenia or schizoaffective disorders. The prevalence of patients who met standardized remission criteria will be also evaluated as well as the predictors fac

P03-119 - Improving use of resources-hea

P03-119 - Improving use of resources-health care in patients with psychiatric pathology after introduction of risperidone long-acting injection (RLAI)

✍ Valdivia, F.; Asensio, M.; Soler, A.; López, L. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 French ⚖ 11 KB

P03-46 - Long-term safety, tolerability

P03-46 - Long-term safety, tolerability and efficacy of risperidone long-acting injectable and oral atypical antipsychotics in schizophrenic patients: two year naturalistic study

✍ Ibach, B.; Rabinowitz, J.; Schreiner, A.; Hargarter, L.; Diekamp, B. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 French ⚖ 34 KB

P03-359 Randomized, double-blind, placeb

P03-359 Randomized, double-blind, placebo-controlled study of risperidone long-acting injectable in relapse prevention in patients with bipolar I disorder

✍ S. Montgomery; E. Vieta; A.H. Sulaiman; R. Cordoba; B. Huberlant; A. Schreiner; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 French ⚖ 66 KB

PMH41 RISPERIDONE LONG ACTING INJECTION

PMH41 RISPERIDONE LONG ACTING INJECTION (RLAI) IN THE TREATMENT OF EARLY VERSUS LATE DIAGNOSIS PATIENTS WITH SCHIZOPHRENIA: INTERIM RESULTS FROM OBSERVATIONAL STUDIES CONDUCTED IN SPAIN, AUSTRALIA AND BELGIUM

✍ JM Olivares; TJR Lambert; J Peuskens; S Caleo; M Povey; A Lam 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB